Delivery Order SPE2DB20D1100-SPE2DB24FD0K7

Award Date 7/31/24
Potential Completion Date 8/1/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4,565,803,530 units of Lidocaine 5% Patches, with a ceiling value of $37,169.03. The contract has a firm fixed-price pricing type and an ultimate completion date of September 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to supply critical medical commodities to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the delivery of 4,565,803,463 units of Lidocaine 5% Patch 30S, a pharmaceutical product, with a ceiling value of $2,424.81. The contract has a firm fixed-price pricing type and a completion date of September 16, 2024. It is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,456,391 Lidocaine 5% Patch 30s. The contract has a ceiling value of $9,058.60 and a completion date of August 15, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts to supply a wide range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,365,492 units of Lidocaine 5% Patches. The contract has a ceiling value of $1,104.26 and an ultimate completion date of August 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,354.52 firm fixed-price contract is for the delivery of 4,568,143,276 units of Lidocaine 5% Patch 30s, a pain management pharmaceutical product. The contract has an ultimate completion date of May 6, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a ceiling value of $5,743.91. This is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of August 23, 2024. The contract does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565297639 - Lidocaine 5% Patch 30s. The contract has a ceiling value of $11,376.15 and an ultimate completion date of July 31, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. As a large pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts by various...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,765.12 firm fixed-price contract is for the delivery of 4,567,951,809 units of Lidocaine 5% Patch 30s, a pain management pharmaceutical product. The contract has an ultimate completion date of April 18, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patch 30s. The contract has a ceiling value of $1,109.20 and a completion date of August 9, 2024. The contract is a Firm Fixed Price delivery order, with no set-aside designation. Amerisourcebergen is the prime contractor, and the contract is part of a larger Indefinite Delivery Contract (IDC) vehicle with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,565,564,026 units of Lidocaine 5% Patch 30s. The contract has a ceiling value of $1,475.76 and a completion date of August 26, 2024. This order is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of essential medical...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD0K7
    Delivery Order

This is a delivery order under a Firm Fixed Price contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,307,730 units of Lidocaine 5% Patch 30s, with a ceiling value of $11,045.75. The contract has an ultimate completion date of August 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various military treatment facilities, veterans' hospitals, and other federal healthcare providers. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, enabling efficient procurement of essential medical commodities. This particular award is not associated with a set-aside program.

Generated 10/30/24, 9:56 AM